{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"XORTX Therapeutics Inc."},"Symbol":{"label":"Symbol","value":"XRTX"},"Address":{"label":"Address","value":"3710-33RD STREET NW SUITE 4000, CALGARY, Alberta, T2L 2M1, Canada"},"Phone":{"label":"Phone","value":"403-455-7727"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes."},"CompanyUrl":{"label":"Company Url","value":"https://www.xortx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Allen Warren Davidoff","title":"President, Chief Executive Officer & Director"},{"name":"David MacDonald","title":"Chief Technology Officer"},{"name":"Stephen Haworth","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}